

1,402,110 filings since 2004 · latest accepted Nov 4, 2026, 11:50 AM ET
Priority items usually mark a change in credit, accounting integrity, control or listing status: 1.02 Agreement terminated, 1.03 Bankruptcy, 1.05 Cybersecurity incident, 2.04 Debt acceleration, 2.05 Restructuring costs, 2.06 Impairment, 3.01 Delisting notice, 4.01 Auditor change, 4.02 Non-reliance (restatement), 5.01 Change in control.
| Filed | Company | Items | Filing |
|---|---|---|---|
May 6, 2026 accepted 4:01 PM ET | LXRXLEXICON PHARMACEUTICALS, INC. | 1.01Material agreement2.03New debt obligation3.02Unregistered equity sale7.01Reg FD disclosure | DocumentSEC ↗ |
Apr 30, 2026 accepted 4:05 PM ET |
Source: SEC EDGAR. Same-day filings appear within minutes and are re-checked against SEC's nightly index. Tickers are current listings, so a company's older filings show its ticker today.
LXRXLEXICON PHARMACEUTICALS, INC. |
1.01Material agreement3.02Unregistered equity sale5.03Bylaws / fiscal year5.07Shareholder vote |
| DocumentSEC ↗ |
Feb 2, 2026 accepted 4:49 PM ET | LXRXLEXICON PHARMACEUTICALS, INC. | 1.01Material agreement3.02Unregistered equity sale3.03Holder rights modified5.03Bylaws / fiscal year7.01Reg FD disclosure | DocumentSEC ↗ |
Jun 3, 2025 accepted 4:04 PM ET | LXRXLEXICON PHARMACEUTICALS, INC. | 1.01Material agreement5.07Shareholder vote | DocumentSEC ↗ |
Mar 28, 2025 accepted 7:59 AM ET | LXRXLEXICON PHARMACEUTICALS, INC. | 1.01Material agreement | DocumentSEC ↗ |
Oct 16, 2024 accepted 4:37 PM ET | LXRXLEXICON PHARMACEUTICALS, INC. | 1.01Material agreement | DocumentSEC ↗ |
Jul 1, 2024 accepted 4:05 PM ET | LXRXLEXICON PHARMACEUTICALS, INC. | 1.01Material agreement | DocumentSEC ↗ |
Mar 11, 2024 accepted 7:26 AM ET | LXRXLEXICON PHARMACEUTICALS, INC. | 1.01Material agreement2.02Earnings release3.02Unregistered equity sale5.03Bylaws / fiscal year7.01Reg FD disclosure | DocumentSEC ↗ |
Dec 29, 2023 accepted 5:29 PM ET | LXRXLEXICON PHARMACEUTICALS, INC. | 1.01Material agreement | DocumentSEC ↗ |
Dec 29, 2023 accepted 4:04 PM ET | LXRXLEXICON PHARMACEUTICALS, INC. | 1.01Material agreement | DocumentSEC ↗ |
Jun 2, 2023 accepted 4:31 PM ET | LXRXLEXICON PHARMACEUTICALS, INC. | 1.01Material agreement3.02Unregistered equity sale7.01Reg FD disclosure | DocumentSEC ↗ |
May 2, 2023 accepted 4:05 PM ET | LXRXLEXICON PHARMACEUTICALS, INC. | 1.01Material agreement | DocumentSEC ↗ |
Apr 27, 2023 accepted 4:29 PM ET | LXRXLEXICON PHARMACEUTICALS, INC. | 1.01Material agreement5.07Shareholder vote | DocumentSEC ↗ |
Sep 2, 2022 accepted 4:01 PM ET | LXRXLEXICON PHARMACEUTICALS, INC. | 1.01Material agreement | DocumentSEC ↗ |
Jul 29, 2022 accepted 5:18 PM ET | LXRXLEXICON PHARMACEUTICALS, INC. | 1.01Material agreement3.02Unregistered equity sale7.01Reg FD disclosure8.01Other events | DocumentSEC ↗ |
Mar 17, 2022 accepted 4:17 PM ET | LXRXLEXICON PHARMACEUTICALS, INC. | 1.01Material agreement2.03New debt obligation3.02Unregistered equity sale7.01Reg FD disclosure | DocumentSEC ↗ |